Literature DB >> 21281613

Diabetes induces early transient changes in the content of vesicular transporters and no major effects in neurotransmitter release in hippocampus and retina.

Filipa I Baptista1, Joana M Gaspar, Armando Cristóvão, Paulo F Santos, Attila Köfalvi, António F Ambrósio.   

Abstract

Diabetes induces changes in neurotransmitter release in central nervous system, which depend on the type of neurotransmitter and region studied. In this study, we evaluated the effect of diabetes (two and eight weeks duration) on basal and evoked release of [(14)C]glutamate and [(3)H]GABA in hippocampal and retinal synaptosomes. We also analyzed the effect of diabetes on the protein content of vesicular glutamate and GABA transporters, VGluT-1, VGluT-2 and VGAT, and on the α(1A) subunit of P/Q type calcium channels, which are abundant in nerve terminals. The protein content of vesicular glutamate and GABA transporters, and of the α(1A) subunit, was differently affected by diabetes in hippocampal and retinal synaptosomes. The changes were more pronounced in the retina than in hippocampus. VGluT-1 and VGluT-2 content was not affected in hippocampus. Moreover, changes occurred early, at two weeks of diabetes, but after eight weeks almost no changes were detected, with the exception of VGAT in the retina. Regarding neurotransmitter release, no major changes were detected. After two weeks of diabetes, neurotransmitter release was similar to controls. After eight weeks of diabetes, the basal release of glutamate slightly increased in hippocampus and the evoked GABA release decreased in retina. In conclusion, diabetes induces early transient changes in the content of glutamate and/or GABA vesicular transporters, and on calcium channels subunit, in retinal or hippocampal synaptosomes, but only minor changes in the release of glutamate or GABA. These results point to the importance of diabetes-induced changes in neural tissues at the presynaptic level, which may underlie alterations in synaptic transmission, particularly if they become permanent during the later stages of the disease.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21281613     DOI: 10.1016/j.brainres.2011.01.071

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  12 in total

1.  Chronic insulinopenia/hyperglycemia decreases cannabinoid CB1 receptor density and impairs glucose uptake in the mouse forebrain.

Authors:  Liane I F Moura; Cristina Lemos; Catherine Ledent; Eugénia Carvalho; Attila Köfalvi
Journal:  Brain Res Bull       Date:  2019-02-02       Impact factor: 4.077

2.  The effects of early diabetes on inner retinal neurons.

Authors:  Erika D Eggers; Teresia A Carreon
Journal:  Vis Neurosci       Date:  2020-09-16       Impact factor: 3.241

3.  Pituitary Adenylate Cyclase Activating Polypeptide, A Potential Therapeutic Agent for Diabetic Retinopathy in Rats: Focus on the Vertical Information Processing Pathway.

Authors:  K Szabadfi; D Reglodi; A Szabo; B Szalontai; A Valasek; Gy Setalo; P Kiss; A Tamas; M Wilhelm; R Gabriel
Journal:  Neurotox Res       Date:  2016-01-06       Impact factor: 3.911

4.  Hierarchical glucocorticoid-endocannabinoid interplay regulates the activation of the nucleus accumbens by insulin.

Authors:  Bárbara S Pinheiro; Cristina Lemos; Fernanda Neutzling Kaufmann; Joana M Marques; Carla S da Silva-Santos; Eugénia Carvalho; Ken Mackie; Ricardo J Rodrigues; Rodrigo A Cunha; Attila Köfalvi
Journal:  Brain Res Bull       Date:  2016-05-18       Impact factor: 4.077

Review 5.  Impairment of Axonal Transport in Diabetes: Focus on the Putative Mechanisms Underlying Peripheral and Central Neuropathies.

Authors:  Filipa I Baptista; Helena Pinheiro; Catarina A Gomes; António F Ambrósio
Journal:  Mol Neurobiol       Date:  2018-07-12       Impact factor: 5.590

6.  Berberine chloride improved synaptic plasticity in STZ induced diabetic rats.

Authors:  Hamid Kalalian Moghaddam; Tourandokht Baluchnejadmojarad; Mehrdad Roghani; Fatemeh Goshadrou; Abdolaziz Ronaghi
Journal:  Metab Brain Dis       Date:  2013-05-03       Impact factor: 3.584

7.  Diabetes alters KIF1A and KIF5B motor proteins in the hippocampus.

Authors:  Filipa I Baptista; Maria J Pinto; Filipe Elvas; Ramiro D Almeida; António F Ambrósio
Journal:  PLoS One       Date:  2013-06-12       Impact factor: 3.240

8.  Diabetes changes expression of genes related to glutamate neurotransmission and transport in the Long-Evans rat retina.

Authors:  Jennifer C M Lau; Roger A Kroes; Joseph R Moskal; Robert A Linsenmeier
Journal:  Mol Vis       Date:  2013-07-19       Impact factor: 2.367

9.  Diabetes causes transient changes in the composition and phosphorylation of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors and interaction with auxiliary proteins in the rat retina.

Authors:  Aurea F Castilho; Joana T Liberal; Filipa I Baptista; Joana M Gaspar; Ana Luísa Carvalho; António F Ambrósio
Journal:  Mol Vis       Date:  2014-06-21       Impact factor: 2.367

Review 10.  Neuroprotection as a Therapeutic Target for Diabetic Retinopathy.

Authors:  Cristina Hernández; Massimo Dal Monte; Rafael Simó; Giovanni Casini
Journal:  J Diabetes Res       Date:  2016-03-31       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.